Početna › Zatajenje bubrega › Arizona
Kliničke studije za Zatajenje bubrega u državi Arizona
6 studija za Zatajenje bubrega traži sudionike na lokacijama u državi Arizona.
Gradovi u državi Arizona
Službeni tekst studije (engleski)
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
- Arizona Clinical Trials - Chandler, Chandler
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 84 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07763418Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- AKDHC Medical, Glendale
- Kidney Disease Medical Group, Glendale
- AKDHC Medical, Phoenix
- i još 2
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- Mayo Clinic in Arizona, Phoenix
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 27. tra 2026. · NCT06552169Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Southwest Kidney Institute, Phoenix
- AKDHC Medical Research Services, Phoenix
- AKDHC Center Tucson, Tucson
U tijeku regrutacija
Od 18 do 84 godina · Oba spola · Ažurirano 13. tra 2026. · NCT06190717SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- AKDHC Bullhead City, Bullhead City
- AKDHC Marana Surgery Center, Marana
- Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center, Phoenix
- i još 1
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2026. · NCT06001827A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- AKDHC Medical Research Services, LLC, Phoenix
U tijeku regrutacija
Od 18 do 90 godina · Oba spola · Ažurirano 22. pro 2025. · NCT04671771Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.